SUMMARY Thyroid function was studied in 54 low birthweight infants during a 3-week period. Each infant was placed in one of three groups. Group 1 (n = 21), infants who were well and appropriately grown for gestational age; group 2 (n = 23), infants who were appropriately grown but who had hyaline membrane disease; group 3 (n = 10), infants who were small forgestational-age. In group 1, 5 (24 %) infants had at least one serum thyroxine value <3 * O ,ug/l00 ml (39 nmol/l). There were 8 (35 %) infants in group 2 who had similarly low serum thyroxine values, as did 5 (50 %) of the 10 infants in group 3. Serum thyrotropin levels and serum binding of thyroid hormones, as measured by a T3-charcoal uptake test, were normal in all infants. In all instances but 2, serum thyroxine values were at least 4-0 [.g/100 ml (51 nmol/l) by the end of the 3-week period.
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There is thus a high incidence of transient 'hypothyroxinaemia' in low birthweight infants, particularly if such infants have hyaline membrane disease or are small-for-gestational-age. These findings must be considered when interpreting results of screening programmes for congenital hypothyroidism and they lend further support to the use of a combination of serum thyroxine and thyrotropin determinations for optimum screening of such infants.
The high incidence of congential hypothyroidism and the usefulness of serum thyroxine (T4) and thyrotropin (TSH) measurements in detecting the disorder has resulted in recommendations for neonatal screening programmes.' Gestational age2 and birthweight [3] [4] Patients (Table 1) were assigned to group 1 (AGA, n = 21) if they were appropriately grown for gestational age and were well or had only mild illness. Group 2 (HMD, n = 23) comprised AGA infants with classical hyaline membrane disease,'0 and group 3 (SGA, n = 10) comprised infants who were SGA and who were well or had only mild illness.
Frequency of transient hypothyroxinaemia in low birthweight infants 215 Measurements of serum T4 and TSH were made by radioimmunoassay as described previously.5 [11] [12] All samples from an individual infant were analysed in the same assay run. Serum binding of thyroid hormones was measured indirectly by a modification of the T3-charcoal technique of Bermudez et al.5 13 The incidence of serum T4 results <3 0 Fg/100 ml was expressed as a percentage of the total number of samples collected. The value of 3-0 ±g/I100 ml was arbitrarily chosen as being very low for a neonatal screening result' 14 and was 2 5 SDs below the mean reported by Cuestas15 for healthy preterm infants in the first 3 months of life.
Results
Serum T4 results at each time period for the three groups are shown in Table 2 ; the ranges indicate the wide variation in serum T4 concentrations in these infants. Table 3 shows the overall high incidence of serum T4 values <3 0 ,ug/100 ml as a function of time, the peak incidence occurring between 3 days and 1 week. Of the total of 260 samples assayed, 25 (9 6 %) had T4 values <3 0 ,ug/100 ml. Of a total of 81 serum T4 measurements at 72 hours and 1 week (the age range generally recommended for screening), 17 (21 %) were <3 0 ,ug/100 ml. Five (24%) infants in group 1 had at least one serum T4 value <3 0 ,ug/100 ml. There were 8 (35%) infants in group 2 who had similarly low values as did 5 (50 %) of the 10 infants in group 3. The Figure shows the distribution of serum T4 and TSH results for the groups, expressed as a percentage of the total number of samples for all groups. With 2 exceptions (both infants with HMD who were subsequently normal), all patients had serum T4 concentrations of at least 4 0 ,ug/100 ml (51 nmol/l) by 3 weeks. Similarly, all infants had serum TSH concentrations <12 ,uU/ml at 3 weeks of age.
The T3-charcoal uptake value, an indirect measurement of serum T4-binding capacity (performed on all except 5 of the infants), was normal in all patients. These data exclude decreased serum thyroid hormone binding as the cause of the hypothyroxinaemia. 
Number (and %) with T4 <3-0 g/100 ml 2 (11) 1 (3) 2 (5) 5 (16) Conversion: traditional to SI units 1 ptg/100 ml -13 nmolIl.
Discussion
Our previous observations5 that low serum T4 concentrations can occur transiently after birth in low birthweight infants have now been extended to show that a serum T4 concentration of <3 0 ,ug/100 ml is a remarkably common occurrence. These low levels occurred at some point in the first 3 weeks of life in 24% of AGA babies, in 35% of babies with HMD, and in 50% of those who were SGA. 
